FRESH TRACKS THERAPEUTICS IN (FRTX) Stock Analyst Ratings
NASDAQ:FRTX - Nasdaq - US10802T2042 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to FRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.59. This target is 481.01% above the current price.
FRTX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FRTX.
In the previous month the buy percentage consensus was at a similar level.
FRTX was analyzed by 7 analysts. More opinions would make the average more meaningful.